ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 37 filers reported holding ELEVATION ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,453 | -56.2% | 21,813 | +0.4% | 0.06% | -42.1% |
| Q2 2023 | $33,022 | -74.6% | 21,725 | -68.2% | 0.10% | -71.0% |
| Q1 2023 | $129,815 | +100.3% | 68,324 | 0.0% | 0.33% | +97.6% |
| Q4 2022 | $64,800 | -15.8% | 68,324 | +0.0% | 0.17% | +14.5% |
| Q3 2022 | $77,000 | -19.8% | 68,297 | +0.0% | 0.14% | +12.4% |
| Q2 2022 | $96,000 | -44.2% | 68,293 | +0.0% | 0.13% | -39.7% |
| Q1 2022 | $172,000 | -48.3% | 68,279 | +23.5% | 0.21% | -21.3% |
| Q4 2021 | $333,000 | -11.2% | 55,299 | +14.8% | 0.27% | -10.5% |
| Q3 2021 | $375,000 | -30.2% | 48,183 | +21.7% | 0.30% | -17.4% |
| Q2 2021 | $537,000 | – | 39,586 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $38,470,000 | 6.16% |
| venBio Partners LLC | 2,608,167 | $35,393,000 | 4.18% |
| Samsara BioCapital, LLC | 932,239 | $12,650,000 | 1.56% |
| Cormorant Asset Management, LP | 1,983,165 | $25,566,000 | 0.87% |
| BVF INC/IL | 1,590,291 | $21,580,000 | 0.81% |
| Boxer Capital, LLC | 1,341,530 | $18,205,000 | 0.64% |
| Ghost Tree Capital, LLC | 100,000 | $1,357,000 | 0.37% |
| CAXTON CORP | 39,586 | $537,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,999,514 | $26,456,000 | 0.35% |
| Vivo Capital, LLC | 496,843 | $6,742,000 | 0.29% |